跳至主要内容
临床试验/EUCTR2009-016743-18-GB
EUCTR2009-016743-18-GB进行中(未招募)1 期

A feasibility study of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer - ICG10

Cambridge University Hospitals NHS Foundation Trust0 个研究点目标入组 100 人开始时间: 2010年6月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - biopsy proven invasive breast cancer in women over 18.
  • - tumours measuring < 5cm in maximum diameter radiologically (mammography, ultrasound or MRI)
  • - no evidence of pathological axillary lymph nodes, clinically or on ultrasound scan.
  • - SLNB recommended as part of their surgical management for breast cancer.
  • - able to give written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - history of previous breast cancer
  • - women unable to provide informed consent
  • - prior axillary surgery or a diagnostic excision biopsy of the breast
  • - pregnant or lactating women
  • - hypersensitivity to indocyanine green or to sodium iodide
  • - hypersensitvity to iodine
  • - patients with hyperthyroidism or patients with toxic thyroid adenomas
  • - unable to give written informed consent

研究者

相似试验